Profile data is unavailable for this security.
About the company
Santen Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, and sale of pharmaceuticals. The Company engages in global research and development, manufacture, sale, and marketing of pharmaceuticals in the ophthalmology field. The Company engages in prescription pharmaceuticals, over-the-counter pharmaceuticals, medical devices, and other businesses. The Company operates in Japan, Asia, Europe, the Middle East, and Africa (EMEA), China, and other regions.
- Revenue in JPY (TTM)287.99bn
- Net income in JPY30.60bn
- Incorporated1925
- Employees3.85k
- LocationSanten Pharmaceutical Co Ltd3-9-19, Shimo-Shinjo, Higashiyodogawa-kuOSAKA-SHI 530-8552JapanJPN
- Phone+81 676648621
- Fax+81 663593827
- Websitehttps://www.santen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zeria Pharmaceutical Co Ltd | 86.61bn | 7.26bn | 113.79bn | 1.75k | 13.51 | 1.02 | 7.82 | 1.31 | 164.79 | 164.79 | 1,964.97 | 2,178.21 | 0.5366 | 1.27 | 3.21 | 49,607,640.00 | 4.49 | 4.67 | 6.99 | 7.47 | 72.76 | 72.17 | 8.37 | 9.02 | 0.9739 | 11.41 | 0.2984 | 28.75 | 15.30 | 7.64 | 28.52 | 27.71 | 16.51 | 6.69 |
| Mochida Pharmaceutical Co Ltd | 111.92bn | 6.42bn | 141.19bn | 1.51k | 21.42 | 1.00 | 15.04 | 1.26 | 181.16 | 181.16 | 3,156.95 | 3,876.77 | 0.6427 | 1.67 | 3.02 | 74,214,190.00 | 3.69 | 4.50 | 4.47 | 5.44 | 48.43 | 52.49 | 5.74 | 6.87 | 2.85 | -- | 0.0678 | 43.01 | 2.21 | 0.6516 | 25.03 | 4.34 | 1.98 | 0.00 |
| Kaken Pharmaceutical Co Ltd | 75.66bn | -3.83bn | 189.36bn | 1.13k | -- | 1.11 | -- | 2.50 | -97.11 | -97.11 | 1,980.56 | 3,850.39 | 0.4091 | 1.86 | 2.80 | 67,195,380.00 | -2.07 | 5.99 | -2.42 | 6.87 | 53.09 | 56.17 | -5.06 | 12.91 | 3.21 | -- | 0.0257 | 59.58 | 30.52 | 1.05 | 73.77 | -6.36 | 14.81 | 0.00 |
| Kissei Pharmaceutical Co Ltd | 95.29bn | 14.14bn | 218.98bn | 1.78k | 13.94 | 0.9013 | 11.59 | 2.30 | 337.47 | 337.47 | 2,274.29 | 5,220.29 | 0.3748 | 1.85 | 2.83 | 53,596,180.00 | 5.62 | 4.26 | 6.19 | 4.60 | 48.21 | 48.59 | 14.99 | 14.30 | 3.42 | -- | 0.0058 | 32.41 | 16.87 | 6.91 | 7.18 | 33.54 | 31.04 | 13.97 |
| Towa Pharmaceutical Co Ltd | 269.92bn | 21.44bn | 223.06bn | 4.79k | 9.94 | 1.12 | 5.12 | 0.8264 | 435.61 | 435.61 | 5,483.17 | 3,853.29 | 0.5695 | 1.49 | 3.37 | 56,374,690.00 | 4.52 | 3.89 | 5.53 | 5.07 | 36.72 | 37.81 | 7.94 | 6.61 | 1.54 | 32.77 | 0.5519 | 21.52 | 13.89 | 18.65 | 17.39 | 5.53 | 46.23 | 9.73 |
| Sawai Group Holdings Co Ltd | 200.68bn | -1.25bn | 275.26bn | 3.31k | -- | 1.54 | 19.05 | 1.37 | -9.86 | -22.64 | 1,734.07 | 1,548.25 | 0.5445 | 1.28 | 3.40 | 60,628,400.00 | -0.3389 | -0.2327 | -0.4542 | -0.3187 | 28.89 | 32.95 | -0.6224 | -0.475 | 1.08 | -1.04 | 0.4066 | 191.65 | 6.88 | 0.7009 | -87.38 | -35.38 | 8.65 | 4.11 |
| Tsumura & Co | 189.50bn | 29.01bn | 314.56bn | 4.27k | 10.59 | 1.00 | 7.38 | 1.66 | 387.15 | 387.15 | 2,524.84 | 4,095.99 | 0.374 | 0.7106 | 2.41 | 44,357,680.00 | 6.01 | 5.53 | 8.06 | 6.85 | 47.60 | 49.39 | 16.06 | 14.50 | 1.45 | -- | 0.2856 | 31.65 | 20.05 | 8.00 | 94.10 | 18.69 | 23.07 | 16.27 |
| Nippon Shinyaku Co Ltd | 166.05bn | 29.85bn | 355.68bn | 2.24k | 11.42 | 1.20 | 9.82 | 2.14 | 443.17 | 443.17 | 2,465.26 | 4,211.80 | 0.5421 | 1.17 | 3.19 | 74,028,980.00 | 9.75 | 10.89 | 10.81 | 12.74 | 67.29 | 63.93 | 17.98 | 17.67 | 4.04 | -- | 0.0089 | 30.58 | 8.08 | 6.56 | 25.94 | 14.06 | 80.48 | 7.59 |
| Hisamitsu Pharmaceutical Co Inc | 159.27bn | 19.99bn | 469.40bn | 2.80k | 22.55 | 1.63 | 17.05 | 2.95 | 276.99 | 276.99 | 2,208.13 | 3,837.32 | 0.4704 | 2.64 | 3.42 | 56,901,390.00 | 6.04 | 4.34 | 7.25 | 4.99 | 59.05 | 57.83 | 12.84 | 10.32 | 3.28 | -- | 0.0086 | 50.29 | 10.09 | 2.04 | 55.76 | 3.08 | 29.89 | 0.7127 |
| Santen Pharmaceutical Co Ltd | 287.99bn | 30.60bn | 552.54bn | 3.85k | 18.63 | 1.95 | 11.34 | 1.92 | 92.03 | 92.03 | 865.27 | 880.97 | 0.7205 | 2.26 | 4.18 | 74,823,070.00 | 7.63 | 3.94 | 9.43 | 4.93 | 56.89 | 58.97 | 10.59 | 6.01 | 1.89 | -- | 0.1757 | 71.86 | -0.6494 | 4.43 | 36.09 | 8.94 | 3.61 | 5.92 |
| Rohto Pharmaceutical Co Ltd | 335.80bn | 34.48bn | 571.32bn | 9.14k | 16.31 | 1.90 | 10.98 | 1.70 | 148.28 | 148.28 | 1,444.67 | 1,272.14 | 0.7768 | 2.32 | 4.55 | 36,723,640.00 | 8.02 | 8.59 | 11.20 | 11.70 | 56.06 | 57.78 | 10.33 | 10.57 | 1.43 | -- | 0.1452 | 21.12 | 13.95 | 10.38 | 0.2263 | 15.01 | 10.42 | 22.59 |
| Sumitomo Pharma Co Ltd | 453.40bn | 110.09bn | 1.17tn | 3.83k | 10.58 | 4.03 | 8.86 | 2.57 | 277.11 | 277.11 | 1,141.22 | 727.28 | 0.5438 | 1.95 | 3.99 | 118,318,100.00 | 13.20 | -5.49 | 23.02 | -8.49 | 59.24 | 67.88 | 24.28 | -13.24 | 1.01 | 4.17 | 0.4726 | -- | 26.79 | -3.75 | 107.50 | -10.32 | -0.4856 | -- |
| Ono Pharmaceutical Co Ltd | 509.35bn | 62.40bn | 1.29tn | 4.29k | 19.54 | 1.45 | 13.02 | 2.54 | 132.76 | 132.76 | 1,084.01 | 1,786.88 | 0.4702 | 2.14 | 3.38 | 118,811,500.00 | 5.77 | 10.78 | 6.61 | 12.37 | 69.79 | 73.23 | 12.27 | 21.23 | 2.56 | 125.26 | 0.1283 | 36.33 | -3.14 | 10.73 | -60.89 | -3.47 | -18.66 | 12.20 |
Data as of Feb 20 2026. Currency figures normalised to Santen Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
37.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 07 Oct 2025 | 31.56m | 9.79% |
| Nomura Asset Management Co., Ltd.as of 31 May 2024 | 19.14m | 5.94% |
| Black Creek Investment Management, Inc.as of 15 Oct 2024 | 13.74m | 4.26% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 11.40m | 3.54% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 9.69m | 3.01% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Sep 2025 | 9.66m | 3.00% |
| Amova Asset Management Co., Ltd.as of 15 Sep 2025 | 9.29m | 2.88% |
| BlackRock Japan Co. Ltd.as of 29 Nov 2024 | 7.04m | 2.18% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 4.68m | 1.45% |
| BlackRock Fund Advisorsas of 29 Nov 2024 | 4.21m | 1.31% |
More ▼
Data from 31 Dec 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
